| Submit your comments on this article |
| Science & Technology |
| Media Should Do A Mea Culpa as French Analysis Offers a Stunning Observation About Hydroxychloroquine Use |
| 2020-07-16 |
| [PJMedia] We have been told repeatedly by health experts to demonstrate the effectiveness of hydroxychloroquine and the other meds prescribed with it we need strict clinical trials. These are studies where some patients receive medication, and some do not. For many healthcare providers, this is a noxious thought if there is evidence to believe a treatment may work. How do you ethically deny a potential treatment to an eligible patient to conduct a study? So-called double-blind studies described above are the preferred method advocated by Dr. Fauci. These double-blind studies allow people to die in the name of “science” if a drug is effective. They are in the “control group.” There are ethical issues with this approach that researches at the University of Pittsburgh Medical Center addressed with a new concurrent trial based on machine learning developed following the H1N1 pandemic. This method has been ignored by the NIH and FDA approval processes. Such was the fate of the hydroxychloroquine, azithromycin, and zinc combination. Scientifically there was every reason to believe it would work. Clinically, doctors saw results when directly treating patients. Several recommended that the drug be produced in sufficient amounts and given early and outpatient. President Trump expressed optimism based on studies in France and China, and the media freaked out. The president’s political opposition would go on to cling to any proof the drug would not work and suppress any information that it would. This politicization culminated in the horrific study published by Lancet that the publication quietly retracted. However, the damage was already done. The World Health Organization suspended trials immediately after the study published in Lancet. Switzerland, which had been using the treatment, prohibited the use of the drug in COVID-19 shortly after that on May 27th. The retraction was so stealth that the ban was not lifted in Switzerland until June 11th. This window allowed French researchers to analyze what happened in the entire population of COVID-19 patients during the ban. They used the case fatality rate (CFR) as the measure observed. The graph is stunning. It also the only period where the Swiss CFR approached or exceeded that in France where there has been no use of hydroxychloroquine outside a few isolated trials. The CFR returned to the highest level it had been since early in the pandemic at over 15%. Upon resumption of treatment with hydroxychloroquine, it returned to below 5%. A statistical analysis of the data: A statistically significant difference For those who have forgotten statistics, a p-value of 0.05 or less indicates statistical significance. If the graph is not convincing, a confidence interval of 99% in a statistical analysis based on full population data should be. Between this information and a study published by researchers in India, it is time for the media to do a mea culpa. Their hysteria convinced politicians in the United States to ban or restrict the drug. |
| Posted by:Elmerert Hupens2660 |
| #8 I will lose all my rents |
| Posted by: g(r)omgoru PB 2020-07-16 12:45 |
| #7 @Grom, Your shares in medical "research" being hit by the fact the second lockdown won't happen and there's little need for COVID products for the general population? |
| Posted by: Bright Pebbles 2020-07-16 12:43 |
| #6 If thee is a safe, cheap and effective treatment, then people won't be scared. If people aren't scared, then you can't shut down the economy. And if you don't shut down the economy, Trump will be reelected. |
| Posted by: Iblis 2020-07-16 11:25 |
| #5 hydroxychloroquine, azithromycin, and zinc combination isn't on a rent-seeking patent You haven't mentioned rent-seeking in weeks, BP. I was beginning to worry. 😁 |
| Posted by: g(r)omgoru 2020-07-16 08:17 |
| #4 >hydroxychloroquine, azithromycin, and zinc combination isn't on a rent-seeking patent. So it won't be recommended. |
| Posted by: Bright Pebbles 2020-07-16 08:00 |
| #3 Yeah. But Trump said it was a good idea. So there! |
| Posted by: Richard Aubrey 2020-07-16 07:10 |
| #2 Till you put teeth in accountability for fake, fabricated, and phony 'news' Of course, if you do, it would - eventually - be used to suppress news that are "factual but not true". |
| Posted by: g(r)omgoru 2020-07-16 06:29 |
| #1 Till you put teeth in accountability for fake, fabricated, and phony 'news', they'll never really care about the sub-standard quality of their product. They're corporations. They should be treated like any corporation for shoddy products. |
| Posted by: Procopius2k 2020-07-16 05:31 |